Condition: Rheumatoid Arthritis · Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
This study will evaluate the retention rates of two advanced therapies, Tumour Necrosis Factor (TNF) and Janus kinase inhibitor (JAK) in the treatment of adults with Rheumatoid Arthritis (RA) over a two year period. It will also examine the ability to embed a clinical trial in a clinical situation using an electronic medical record (EMR).
This description comes directly from the study's public registry record.
Janet E Pope, MD MPH · 519 646-6000 · janet.pope@sjhc.london.on.ca
Always discuss trial participation with your own doctor first.
| Rheumatology Clinic, St. Joseph's Health Care | London, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03976245